Key result
Despite high rates of cardioprotective medication use, a large proportion of coronary patients failed to meet secondary prevention targets, with 54% having elevated blood pressure and 56.8% elevated LDL-cholesterol.
Cross-Sectional (n=493)
Yes
Despite high rates of evidence-based pharmacotherapy prescription, a large proportion of Czech patients with coronary heart disease fail to achieve secondary prevention targets for blood pressure, LDL cholesterol, and lifestyle factors.
Answers are grounded in this paper and cite their sources.
Reveals gaps in secondary prevention target attainment despite pharmacotherapy; leaves open optimal implementation strategies in coronary patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mayer et al. (2008) conducted a cross-sectional in Coronary heart disease (n=493). Secondary prevention guidelines implementation was evaluated on Proportion of patients achieving secondary prevention treatment goals. Despite high rates of cardioprotective medication use, a large proportion of coronary patients failed to meet secondary prevention targets, with 54% having elevated blood pressure and 56.8% elevated LDL-cholesterol.
Synapse has enriched 10 related papers. Consider them for comparative context: